MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 13.11.2023
Orchard Therapeutics plc P/S 2011-2025 | ORTX
P/S Jährlich Orchard Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.7 | 97.7 | 221 | 479 | 134 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 479 | 29.7 | 192 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptevo Therapeutics
APVO
|
3.11 | $ 0.55 | -10.23 % | $ 152 K |  USA |
 |
Aclaris Therapeutics
ACRS
|
8.13 | $ 3.03 | -0.17 % | $ 234 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.09 | -2.68 % | $ 7.43 B |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.79 | 7.19 % | $ 457 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
105 | $ 1.18 | 3.07 % | $ 6.43 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Ascendis Pharma A/S
ASND
|
947 | $ 208.29 | -0.33 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 0.19 | -12.16 % | $ 413 M |  Israel |
 |
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
35.7 | $ 94.51 | -0.01 % | $ 27.2 B | Germany |
 |
Catalyst Biosciences
CBIO
|
0.296 | $ 12.02 | -2.67 % | $ 791 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 27.09 | -0.11 % | $ 1.31 B | USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | USA |
 |
Anika Therapeutics
ANIK
|
2.24 | $ 9.53 | -0.21 % | $ 140 M | USA |
 |
Certara
CERT
|
5.15 | $ 8.86 | -0.39 % | $ 1.42 B | USA |
 |
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | USA |
 |
Cellectis S.A.
CLLS
|
6.69 | $ 4.93 | 3.79 % | $ 116 M |  France |
 |
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
19.1 | $ 581.66 | -0.37 % | $ 44.1 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
0.237 | $ 2.45 | - | $ 15.4 M | USA |
 |
AstraZeneca PLC
AZN
|
2.17 | $ 92.77 | -0.14 % | $ 96.9 B | Britain |
 |
ChromaDex Corporation
CDXC
|
4.32 | - | -0.88 % | $ 598 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
6.35 | $ 9.21 | 1.32 % | $ 1.49 B | Britain |
 |
Celldex Therapeutics
CLDX
|
0.187 | $ 26.14 | -1.0 % | $ 1.68 M | USA |